arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Airsculpt Technologies, Inc.

AIRS
$5.01 ▲ +0.25 (+5.25%) at close
Industrials ·Services-Offices & Clinics of Doctors of Medicine ·USServices-Offices & Clinics of Doctors of Medicine
7 Visible periods
33 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Bearish
auto_awesome

Analytical Summary

Airsculpt Technologies, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $302.9M
Dividend Yield
Revenue Growth -15.8%
Op. Margin -7.6%
ROIC -5.3%
FCF / Share $0.01
Trailing P/E
Price / Book 3.7x
FCF Yield 0.2%
Debt / Equity 0.64
info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$151.82M
↓ -15.8%
Net Income Profit after all expenses
$-11.67M
↓ -45.5%
Operating Margin Operating profit as % of sales
-7.6%
↓ -767.5% 17th
FCF / Share Free cash flow per share
$0.01
↑ +124.9%
Long-Term Debt Long-term obligations
$56.05M
↓ -19.6%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
21
Returns
32
Financial Health
42
Cash Quality
20

Dividend History

Dividend / share · sourced from SEC filings
$0.41 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 22 quarters